The Expression and Clinical Significance of Matrix Metalloproteinase-9 and Vascular En-Dothelial Growth Factor in Ovarian Cancer Tissue
Fu Liye,Tian Xin,Li Yan,Meng Fandong,Jiang Tao,Jiang Youhong
DOI: https://doi.org/10.3969/j.issn.1672-4992.2017.22.030
2017-01-01
Abstract:Objective:To observe the expression of matrix metalloproteinase-9 (MMP-9)and vascular endo-thelial growth factor (VEGF)of oarian cancer patients,to analyze the clinical significance of MMP-9 and VEGF ex-pressions in ovarian cancer.Methods:60 ovarian cancer tissues were selected as malignant group,60 cases of benign ovarian tumor were selected as benign group and 60 healthy ovarian tissues were obtained as health group.Immunohis-tochemical method was applied to detect the MMP-9 and VEGF positive expressions in ovarian tissues.RT-PCR was applied to detect the relative expressions of MMP-9mRNA and VEGF mRNA in different ovarian tissues,the Western blot was applied to detect MMP-9 and VEGF protein levels.the MMP-9 and VEGF expression were com-pared in ovarian tissues with different clinical pathological characteristics.Results:In malignant group,MMP-9 positive rate (53.33%),strong positive rate (25.00%)and VEGF positive rate (55.00%),strong positive rate (26.67%) were significantly higher than other groups (P< 0.05).In benign group,MMP-9 positive rate (23.33%),VEGF positive rate (26.67%)were significantly higher than healthy group (P< 0.05).In malignant group,MMP-9 mR-NA,MMP-9 protein and VEGF mRNA,VEGF protein were significantly higher than other groups,followed by benign group.The differences expression of MMP-9 and VEGF were significant in the three groups (P< 0.05).There were significant differences in the expression of MMP-9 and VEGF in ovarian tissue with different clinical and lymph node metastasis (P< 0.05),and the expression of MMP-9 and VEGF had significant positive correlation (P< 0.05).Conclusion:MMP-9 and VEGF were highly expressed in ovarian cancer,and the expression intensity was closely re-lated to the clinical stages and lymph node metastasis of ovarian cancer.